Wedoany.com Report on Feb 2nd, Munich-based biotech startup Twogee Biotech recently announced the completion of a €2.16 million seed funding round. The company is dedicated to transforming biomass industry byproducts into sustainable raw materials through customized enzyme solutions. This round of investment includes High-Tech Gründerfonds (HTGF), Bayern Kapital, as well as strategic partners AgriFoodTech Venture Alliance and Heinz Entsorgung.
Twogee Biotech's core technology lies in converting low-value biomass residues and by-products into second-generation raw materials, with a particular focus on sugar production for biological and synthetic biology applications. The company employs a predictive development platform that integrates enzyme screening, strain engineering, and fermentation processes, effectively shortening development cycles and reducing scale-up risks.
Founded in 2024 by Frank Wallrapp and Helge Jochens, both founders bring over a decade of industry experience in biotechnology and have received support from the BioM MAxL incubator. The company has currently completed initial Minimum Viable Product (MVP) development and has conducted paid pilot projects with industrial partners.
Frank Wallrapp, CEO of Twogee Biotech, stated: "Many industrial residual streams hold immense untapped commercial value. We help our partners unlock this potential with minimal integration effort and a clear economic value proposition." Helge Jochens, CTO, added: "The funding will primarily be used to expand the IZB laboratory with predictive bioreactor systems and to strengthen the process and scale-up expert team."
Through a licensing model, Twogee Biotech supports customers in local enzyme production, thereby reducing costs and CO2 emissions, and promoting the formation of decentralized, circular value chains. Tilmann Petersen, Investment Manager at HTGF, commented: "Twogee's enzyme technology builds a true enabler for the circular economy, aligning sustainability with profitability." Monika Steger, Managing Director of Bayern Kapital, stated that the company's technology integrates resource efficiency, sustainability, and industrial scalability, demonstrating significant development potential.
Following this funding round, Twogee Biotech will accelerate its technology development and commercialization processes, providing technical support to industrial companies seeking to transition towards circular, low-carbon value creation systems. The company's innovative practices in sustainable biomass conversion offer new solutions for the green transformation of the chemical industry.
